Skip to main content
. 2020 Jan 13;11:239. doi: 10.1038/s41467-019-13897-6

Fig. 1. Monomerization of dimeric miRFPs.

Fig. 1

a Dimerization interface in RpBphP2-derived iRFPs. The residues substituted based on alignment with RpBphP1-derived miRFPs are in yellow. The BV chromophore is in blue. The model is based on RpBphP2-PAS-GAF structure (PDB ID: 4R6L). b Alignment of C-termini from parental BphPs, i.e. RpBphP1, RpBphP2 and RpBphP6, monomeric RpBphP1-derived miRFPs, and monomerized iRFPs of RpBphP2 and RpBphP6 origins. The substituted residues are marked in yellow. c Fusions of miRFP713 (representative monomerized iRFP derived from RpBphP2) and miRFP670–2 (representative monomerized iRFP derived from RpBphP6) labeling actin (LifeAct) and tubulin in live HeLa cells. Scale bar, 10 µm. d Brightness of monomerized iRFPs in comparison with dimeric iRFPs and previously reported monomeric NIR FPs. Columns are highlighted according to the origin of NIR FPs (RpBphP2-derived FPs in red, RpBphP6-derived in green and RpBphP1-derived in cyan) and their oligomeric state (dimeric are dashed, monomeric are plain). Error bars are double s.e.m. (n = 3; transfection experiments).